Skip to main content
Premium Trial:

Request an Annual Quote

Ag Genomics: Monsanto Closes Cereon, Keeps Millennium Partnership

Premium

Cereon Genomics, a wholly owned subsidiary of Monsanto and a product of a long-term collaboration with Millennium Pharmaceuticals, has been shut down. The Cambridge, Mass., facility, home to approximately 140 employees, “will not be part of our system around mid-year,” says Monsanto spokeswoman Lori Fisher.

The decision coincides with a restructuring plan underway at Monsanto, which will cost as much as $124 million and would cut about five percent of its worldwide staff — between 600 and 700, the majority of which would be in New Zealand, southeastern Asia, Australia, and North America, Fisher says. Some of the Cereon staff will assume positions within Monsanto, but she could not say how many.

“It’s a tough decision,” Fisher says. “Cereon has been extraordinarily successful … in structural and functional genomics.”

Fisher stressed that the decision to shut down Cereon, which was launched in 1997, has not affected Monsanto’s broader collaboration with Millennium. Monsanto also has ongoing relationships with Affymetrix, Bangalore Genomics, Ceres, danforth plant sciences Center, IBM, Incyte, Mystic Genomics, Orchid BioSciences, Paradigm, Rosetta, and Third Wave Technologies.

— Kirell Lakhman

 

The Scan

Nature Papers on Long Reads for Bacterial Genomes, Zebrafish Atlas, Hypothalamic Aging in Mammals

In Nature this week: near-finished microbial genomes without polishing, zebrafish functional annotation program, and more. 

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.